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ABSTRACT 
Introduction: Twin-to-Twin Transfusion Syndrome (TTTS) is a prenatal condition 
affecting 10-20% of monochorionic – diamniotic (identical) twins and is defined 
by unbalanced blood flow from one twin to the co-twin.  TTTS is staged using the 
Quintero Staging System (I-V) based on ultrasound and Doppler findings.  Even 
with the staging, TTTS does not have a linear course of progression and lacks 
predictably in the outcome of the pregnancy. If it does progress and is left 
untreated, TTTS has a 100% mortality of both twins.  There are various 
treatments for TTTS including septostomy and serial amnioreductions, but the 
optimal treatment for TTTS is laser ablation of the communicating placental 
vessels between both twins.  These anastomoses are the pathophysiological 
cause of the syndrome and LASER treatment allows the twins to recover in 
utero.  LASER treatment is associated with risks, including preterm rupture of 
membranes and preterm labor in 4% of pregnancies and short-and long-term 
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morbidities in 13% of the twin, with the main cause of all morbidity in TTTS 
infants being prematurity.  Twin-to-Twin Transfusion Syndrome’s associated 
unpredictability, lack of linear progression, and various risks and outcomes cause 
decision-making in TTTS to be problematic for both physicians and parents.        
Methods:  A six-month observational period from July 2012 through January 
2013, a cohort of women pregnant with monochorionic – diamniotic twins were 
referred to the Fetal Treatment Program of New England for assessment of 
TTTS in their twins by ultrasonography.  If diagnosed with TTTS, the twins were 
staged (I-IV) and treatment recommendations were discussed.  At Stage I, 
patients were recommended for observational, conservative management of 
weekly ultrasounds.  If the patient’s ultrasound findings were consistent with 
Stage II, III, or IV, they underwent LASER treatment.  During LASER treatment, 
communicating anastomoses between both twins were ablated using a diode 
laser.  The women were discharged 2 days post-op and were recommended to 
have at least weekly ultrasounds for the first two weeks after surgery and then 
every other week ultrasounds thereafter, to monitor each twin’s health.  
Results:  Of all the women referred, 11 different scenarios of severe Twin-to-
Twin Transfusion Syndrome were observed.  Each scenario differed in initial 
diagnosis, overall progression, and final outcomes of the pregnancy.  Each also, 
differed in physician and parental decision-making and emotions expressed and 
experienced. 
 vii 
Conclusions:  Physicians struggle ethically and parents struggle morally with 
the decisions associated in severe TTTS because there is no correct answer.  
But, if they both view the dilemmas through a “veil of ignorance” and respect 
each party’s autonomy in decision-making, the struggles can be resolved and all 
parties, including the twins, can benefit.   
 viii 
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 In the past 25 years, there has been an increase in twin pregnancies in the 
United States.  From 1980, the twin birth rate has increased by 76% and as of 
2009 there were 33.2 twin births per 1,000 total births (Martin et al., 2011).  This 
increase in twin pregnancies, and multi-fetal gestations in general, is said to be 
due to women waiting to have children at a later age (advanced maternal age) 
and also due to the advances in assisted reproductive technology (ART), 
including in vitro fertilization (IVF) and surrogacy.  When considering just twin 
pregnancies, only one-third are characterized as monozygotic, or from the same 
fertilized ovum, and of those one-third, roughly 75% are monochorionic- 
diamniotic, i.e. share one placental mass, but have two amniotic sacs separated 
by a thin intertwin membrane (Cordero, Franco, Joy, & O’Shaughnessy, 2005).  
Altogether, monochorionic (MC) twins account for 20% of spontaneous twin 
pregnancies and about 5% of ART pregnancies (Lewi, Deprest, & Hecher, 2013).   
 Compared with dichorionic (DC) twins, MC twins have a higher mortality 
rate (12% prior to 24 weeks gestation, versus 2% mortality rate of DC twins 
(Sebire, Snijders, Hughes, Sepulveda, & Nicolaides, 1997)).  The increased 
mortality of MC twins is said to be due to the single maternal placenta the twins 
share, which allows vascular anastomoses to form on the chorionic plate and 
blood to flow between both twin fetuses (Lewi et al., 2013).  Based on placenta 
injections studies, these vascular connections can lay on the surface of the 
chorionic plate or deep within the placenta’s parenchyma (De Paepe et al., 
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2010).  The superficial anastomoses are defined as artery-to-artery (AA) and 
vein-to-vein (VV) and act as direct connections from twin to twin (De Paepe et al., 
2010; Lewi et al., 2013).  The deep placental anastomoses are artery-to-vein 
(AV) and are distinct from AA or VV because they are unidirectional and contain 
a shared cotyledon, with an arterial supply from one twin and a venous run-off to 
the other twin (De Paepe et al., 2010; Lewi et al., 2013).  Many prenatal 
complications can result from the shared placental mass and communicating 
anastomoses between the twin fetuses.  These include intertwin size or amniotic 
fluid discordance, intrauterine growth restriction (IUGR), fetal demise, and 
hemodynamic twin discordances, like twin to twin transfusion syndrome (TTTS), 
twin reversed arterial perfusion (TRAP), or twin anemia polycythemia sequence 
(TAPS) (Chalouhi et al., 2011).       
 Severe TTTS appears in about 10-20% of monochorionic-diamniotic twins 
(Chalouhi et al., 2011; J. De Lia et al., 2000).  It is defined by an unbalanced 
blood flow from one twin (Donor) to the co- twin (Recipient) through the placental 
anastomoses described above (Lombardo et al., 2011).  Even though all 
monochorionic-diamniotic twin pregnancies have placental vessel 
communications between the twins, the presence of deep, unidirectional AV 
connections creates an imbalance, uncompensated flow from donor to recipient 
and is a critical factor in the development and persistence of TTTS (De Paepe et 
al., 2010; van Gemert et al., 2008).  Specifically, the uneven distribution of AV 
anastomoses and uneven flow from a twin’s vascular bed to the other twin’s 
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vascular bed, triggers an adaptive redistribution of intravascular and amniotic 
fluid volume and triggers an endocrine/physiologic response, the renin-
angiotensin-aldosterone system, which is appropriate in one twin (the donor) and 
impacts the other twin (the recipient) in an inappropriate way (Muratore et al., 
2009).  In contrast, the presence of AA anastomoses are believed to be a 
protective feature in TTTS by compensating for the imbalance created by the 
unequal AV flow (Denbow, Cox, Taylor, Hammal, & Fisk, 2000; Umur, van 
Gemert, Nikkels, & Ross, 2002). Figure 1, below, depicts the difference in 
angioarchitecture between monochorionic-diamniotic placentas affected or not by 
TTTS following placental injection studies (De Paepe et al., 2010).   Overall, it 
was found that monochorionic-diamniotic pregnancies affected with severe TTTS 
show a significantly higher frequency of uneven placental sharing, absence of 
AA, and presence of VV anastomoses, compared with non-TTTS placentas (De 
Paepe et al., 2010).  
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Figure 1. Angioarchitecture in non-TTTS and TTTS affected Placentas. All images are 
monochorionic-diamniotic placentas following vascular injection studies. Images A and B are of a 
placenta not affected by TTTS.  In images A and B, all arteries cross over veins and the color of 
each vessel is labeled as follows, yellow – artery from left and right twin, green - vein from left 
twin, and black – vein from right twin.  The white arrows in image A denote AA anastomosis. 
Image B, which is a magnification of image A, shows numerous AV anastomoses from the left 
twin (yellow) to the right twin (black), which are also indicated by white arrows.  A very small AV 
from the right to the left twin is denoted by a black arrow at the bottom of image B.  Images C and 
D are of a placenta affected by TTTS, where the left is from the donor twin’s side of the placenta 
and right is from the recipient twin’s side of the placenta.  The color-code for images C and D are 
as follows, red – artery from left and right twin, yellow – vein from left twin, and green – vein from 
right twin.  Image C depicts the uneven placental share of the twins, with the donor (left) having a 
smaller share than the recipient (right).  Also, image C shows what is thought to be scarce 
intertwin anastomoses, with white arrows denoting AA anastomosis.  Image D, a magnification of 
image C, actually depicts the numerous AV anastomoses, indicated by the black arrows.  These 
AV anastomoses are from right to left, thus from recipient to donor (Figure amended from De 
Paepe et al., 2010).       
 
 TTTS is usually diagnosed during a follow-up ultrasound for an 
asymptomatic pregnancy around 20 weeks gestational age, but can be 
diagnosed throughout the entire gestation.  If the syndrome is left undiagnosed, 
untreated, and if it progresses, it leads to heart failure and IUGR in the donor twin 
and cardiac overload in the recipient twin, with an overall mortality rate between 
90-100% (Luks, Carr, Muratore, O’Brien, & Tracy, 2009; Robyr et al., 2006).  
Furthermore, if one twin passes away, it can lead to a 68% risk of preterm labor 
or the co-twin having a 25% risk of developing a neurological impairment and a 
15% chance of dying due to exsanguination (Hillman, Morris, & Kilby, 2011; Luks 
et al., 2009; Muratore et al., 2009). 
 Clinical signs of severe TTTS range from oligohydramnios and 
polyhydramnios in the donor and recipient twin, respectively, to fetal hydrops and 
cardiac failure in either twin (R A Quintero et al., 1999).  Because of the broad 
spectrum of clinical manifestations, a standardized staging system was 
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introduced in 1999 and provides physicians with a reproducible classification for 
severe TTTS based on ultrasound and Doppler findings (R A Quintero et al., 
1999). The Quintero Staging System, depicted in Table 1 below, classifies 
severe TTTS in the following manner, Stage I is classified as polyhydramnios 
(MVP ≥ 8cm) in the recipient twin and oligohydramnios (MVP ≤ 2cm) with visible 
bladder in donor twin; Stage II is classified with the same criteria as Stage I, but 
the donor twin’s bladder is no longer visible; Stage III is classified using Stage II 
criteria, but a clinical abnormal Doppler (CAD) is seen (which includes 
absent/reversed end-diastolic velocity (flow) in the umbilical artery, reversal of 
flow in the ductus venosus, pulsatile umbilical venous flow, or mitral or tricuspid 
valve regurgitation (TR)); Stage IV is characterized by the presence of hydrops in 
either twin; and lastly Stage V is classified as a fetal demise or miscarriage (R A 
Quintero et al., 1999). 
Table 1.  Staging of Severe Twin-to-Twin Transfusion Syndrome.  Staging of Twin-to-Twin 
Transfusion Syndrome is based on Sonographic and Doppler findings.  Stage I is defined by 
Polyhydramnios (MVP ≥ 8 cm) and/or Oligohydramnios (MVP ≤ 2 cm) in either twin and a visual 
bladder on donor twin.  Polyhydramnios and/or Oligohydramnios define stage II in either twins 
with no visual bladder on the donor twin.  Stage III is defined by the presence Polyhydramnios 
and/or Oligohydramnios in either twins with no visual bladder on the donor twin and the presence 
of a CAD.  CAD can consists of AEDF or REDF in the umbilical artery, pulsatile umbilical venous 
flow, reverse flow in the ductus venosus, or tricuspid or mitral valve regurgitation.  Stage IV is 
defined by hydrops in either twins, which could consist of ascites, skin edema, and pericardial or 
pleural effusion.  Lastly, Stage V is defined by demise of one or both twins (Table amended from 
R A Quintero et al., 1999). 




CADs Hydrops Demise 
I + - - - - 
II + + - - - 
III +/- +/- + - - 
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IV +/- +/- + + - 
V +/- +/- + + + 
 
 The Quintero Staging System for severe TTTS is widely used, but remains 
controversial.  The current staging is adequate to describe the severity of the 
disease and to dictate the need for intervention, but the staging system lacks the 
capability to predict the direction, rate, or degree of progression of TTTS (Luks et 
al., 2004).  Luks et al. (2004) studied 18 patients with severe TTTS during a 28-
month period where they found that if the syndrome were to evolve, it was just as 
likely to improve, as it was to worsen.  Figure 2, below, shows the degree and 
rate of progression in those 18 patients evaluated and how unpredictable the 
severe TTTS progression was, since some patients progressed rapidly and other 
remained at their current stage for weeks (Luks et al., 2004).  The Quintero 
staging system also lacks the information to evaluate an accurate mortality risk 
after intervention (Muratore et al., 2009).  Muratore et al. (2009), while examining 
the actuarial risk of fetal demise after LASER ablation, found that there was an 
unexpected higher mortality rate in stage III severe TTTS than, in the 
(presumably sicker) stage IV twins.  The inconsistency between stage III and 
stage IV outcomes shows the lack of predictability in the staging system and the 




Figure 2.  Progression of Severe TTTS in Eighteen Patients.  The x-axis indicates the weeks 
after the initial diagnosis of severe TTTS until the patient underwent laser intervention, delivered 
the pregnancy, or experienced a duel fetal demise.  The y-axis indicates the stage criteria the 
patient met, based on the Quintero Staging System.  Overall, there was a lack on consistency in 
the progression of the severe TTTS, regardless of the initial diagnosed stage or timing of end 
point (Figure Amended from Luks et al., 2004).   
 
 With the need of better predictors for progression, some centers have 
augmented the Quintero Staging System to help better predict severity and 
prognosis of the syndrome with an emphasis on cardiomyopathy. In 2007, the 
Children’s Hospital of Philadelphia scoring system was developed to correlate 
with the Quintero staging system, a grade based on severity of cardiovascular 
abnormalities (Rychik et al., 2007).  This study was found to have no clinical 
significance as a prognostic marker in the pregnancy outcome when diagnosed 
with severe TTTS (Stirnemann, Nasr, Proulx, Essaoui, & Ville, 2010b).  There 
has also been development of scoring systems independent of Quintero’s system 
for evaluation of the twins’ cardiovascular function through echocardiographic 
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and peripheral Doppler evaluations (Chalouhi et al., 2011). In 2010, Stirnemann 
et al. (2010a) developed a cardiac profiling that helped in separating TTTS 
patients with significant myocardial dysfunction from those without.  This study 
was also deemed to have no prognostic value towards outcomes in pregnancies 
complicated with severe TTTS (Julien J Stirnemann et al., 2008).     
 Twin-to-Twin Transfusion treatment and management has historically 
consisted of providing therapies that included expectant management, 
amnioreduction, and septostomy.  Expectant management is conservative 
observation of the pregnancy through weekly or bi-weekly ultrasound.  
Amnioreduction is defined as ultrasound-guided normalizing of amniotic fluid 
level associated with polyhydramnios to reduce maternal discomfort, improve 
placental perfusion by lowering the pressure on placental vessels, and 
prolonging the pregnancy (“Amnioreduction,” 2012).   Septostomy is a technique 
involving intentional puncture or rupture of the intertwin membrane under 
ultrasound guidance, which allows the normalization of the amniotic fluid volume 
discrepancy between donor twin’s (oligohydramnios) sac and recipient twin’s 
(polyhydramnios) sac and improvement of fetal Dopplers within a few days after 
the procedure (Hubinont, Bernard, Mwebesa, Magritte, & Donnez, 1996).  These 
treatments are not actually treating the pathophysiology of TTTS, but are treating 
only the manifested symptoms of TTTS.  In 1990, the first reported treatment 
addressing the pathophysiology of TTTS was performed, the endoscopic laser 
occlusion of putative vascular connections between the fetal twins, thereby 
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halting the syndrome (J. E. De Lia, Cruikshank, & Keye, 1990).  Currently, 
endoscopic laser ablation of placental vessels (LASER) is the only treatment for 
TTTS that directly interrupts the physiology of the syndrome by seperating the 
two fetal circulations and allowing time for normalization of urine output, amniotic 
fluid volumes, and cardiac function in both twins (Lewi et al., 2013; Luks et al., 
2009). 
 The original technique of endoscopic laser ablation of placental vessels was 
to obliterate all vessels that cross the intertwin membrane (Ville et al., 1998).  
Throughout the years the technique has become more selective by not ablating 
paired vessels, even if they cross the intertwin membrane, but only ablating the 
unpaired, communicating vessels between the two twins (R A Quintero, Comas, 
Bornick, Allen, & Kruger, 2000).  Quintero et al (2007) also showed that 
sequential selective laser ablation of placental vessels resulted in better overall 
dual twin survival and lowered the risk for intrauterine fetal demise (IUFD) of the 
twins.  The technique is described as ablating the donor-to-recipient 
anastomoses first, then ablating the recipient-to-twin anastomoses to allow for 
decompression of the recipient’s vascular overload before separation of the 
circulations completely (Rubén A Quintero et al., 2007; van Gemert et al., 2008). 
 Laser treatment of severe TTTS prior to 26 weeks gestation was found to 
be a better mode of treatment than other treatments described above, in a 2004 
multi-centered randomized controlled study, the EUROFOETUS trial (Senat et 
al., 2004).  This study, comparing laser and amnioreduction treatments, was 
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terminated early because of the significant benefit to pregnancy outcomes in the 
laser group compared with the amnioreduction group.  There was a 76% 
likelihood of at least one twin surviving up to 28 days of age, compared with a 
56% chance in the amnioreduction group. Because of the repeated invasive 
procedures and recurrence of polyhydramnios associated with amnioreduction, 
there was also a higher incidence of preterm delivery in the amnioreduction 
group (Senat et al., 2004).  At 6-month postnatal follow-up, there was a 
significantly higher long-term survival rate and lower rates of neurological 
complications in the laser group than after amnioreduction (Senat et al., 2004).   
Based on the findings and publication of results of the EUROFOETUS trial, laser 
therapy has been considered by specialists to be the optimal therapy for severe 
TTTS in pregnancies prior to 26 weeks gestation.  This was indicated in one 
center’s evaluation of survival after LASER intervention, where the overall 
survival was 70%, with at least one twin surviving at 80% and both twins 
surviving at 50-60%, consistent with the results found in EUROFOETUS trial 
(Lombardo et al., 2011; Senat et al., 2004). 
    Endoscopic laser fetal surgery, though the optimal treatment, is 
associated with potential risks and complications.  Maternal morbidity includes 
side effects of tocolytic agents, pulmonary edema, placental abruption, 
postoperative vaginal bleeding, chorioamnionitis, and postoperative amniotic leak 
and iatrogenic premature rupture of the membrane (iPROM) (Luks et al., 2009).  
iPROM can lead to chorioamnionitis, fetal pulmonary hypoplasia due to chronic 
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oligohydramnios, and preterm labor which, if it occurs prior to the gestational age 
of viability leads to fetal demise (Luks et al., 2009).  An overall incidence of 
PPROM within 28 days of surgery is around 3.2% and an overall PPROM rate of 
6.3% (Lombardo et al., 2011).  There can also be surgical failure when there are 
residual anastomoses following laser surgery; this occurs in 5-30% of lasered 
placentas (Chmait, Assaf, & Benirschke, 2010; Lopriore et al., 2009).  Surgical 
failure encompasses missed vessels or the revasculization of ablated vessels, 
and may or may not be associated with symptoms (Chalouhi et al., 2011).  In 
about one-third of cases following successful LASER, there are no symptoms 
and the pregnancy outcome is uneventful (Lewi et al., 2006).   Symptomatic 
surgical failure occurs in 18% of cases and includes such complications as 
fetofetal hemorrhage resulting in TAPS, intrauterine demise of both twins, 
hypotensive sequelae of the surviving twin, or persistent, recurrent, or reversed 
TTTS and is dependent on type and size of anastomoses missed (Lewi et al., 
2006; Julien J Stirnemann et al., 2008).  Missed large AV anastomoses may lead 
to recurrent TTTS or double demise of the twins, unless AA anastomoses were 
also missed, which compensates for the unidirectional AV vessel (Lewi et al., 
2013).  If the missed AVs are small in size, it can result in the twins developing 
TAPS several weeks post-surgery (Lewi et al., 2006).     
 Overall, with the various treatments and the associated risks and 
complications, long-term problems in neonates still persist in severe TTTS.  
Survival of the twins remains the main concern in the treatment of TTTS, 
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however it was found that the risk of cerebral palsy in twins is 3- to 6-fold higher 
than in singleton pregnancies, and it affects 5% of TTTS babies, no matter if they 
are the donor or recipient twin (Blickstein, 2002; Lewi et al., 2013).  With the 
establishment of endoscopic laser surgery as primary and optimal treatment of 
severe TTTS, there has been improvement in the long-term outcome of 
survivors, but long-term morbidity still affects 13% of MC twins after treatment 
with fetal laser surgery of severe TTTS (Kowitt et al., 2012; Maschke, Diemert, 
Hecher, & Bartmann, 2011; Salomon et al., 2010).  As for the cardiovascular and 
renal morbidities and the growth discrepancy of the twins who underwent laser 
surgery intervention, LASER allowed twins to recover from the chronic 
hemodynamic imbalance observed prior to surgery (Maschke et al., 2011).  In 
recent studies, it was found that most postnatal morbidities, especially 
neurological, found in neonatal survivors of severe TTTS were based on the 
degree of prematurity (Kowitt et al., 2012; Vanderbilt, Schrager, Llanes, & 
Chmait, 2012).  Specifically, Kowitt et al. (2012) found that in a 4-year follow-up 
postnatally, the children were no worse than GA-matched, non-TTTS twins and 
singletons and that the degree of prematurity was the best predictor of temporary 
and permanent sequela. 
 As mentioned above, TTTS does not have a linear progression and the 
staging system in place does not accurately portray outcomes, and only 
characterizes the severity of the syndrome at a specific time. Furthermore, with 
the possible consequences and risks of LASER surgery and the possibility of 
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long-term problems, there is a paradox with the management of severe TTTS at 
Stage I.   Given the potential for spontaneous regression or lack of progression of 
the syndrome, many centers reserve LASER for the most severely affected 
cases, including Stage III, Stage IV, and persistent Stage II (Luks et al., 2009).  
Some studies have shown progression in less than 10% of stage I severe TTTS 
cases and at least 50% of all stage I cases required no intervention and resulted 
in a good overall outcome (Bebbington et al., 2010).  Luks et al (2009) concluded 
that is was unjustified to recommend routine surgical intervention for all Stage I 
patients in an attempt to salvage a small number that do progress and risk 
potential morbidity in others that may regress.  However, others recommend 
laser intervention for Stage I TTTS patients.  A study showed a 93% survival of 
one at least twin, 75.9% survival of both twins, and better overall long-term 
outcomes with LASER intervention at Stage I (Huber, Diehl, Bregenzer, 
Hackelöer, & Hecher, 2006; Wagner et al., 2009). Currently, a randomized 
controlled trial on Stage I TTTS is enrolling patients with an aim is to evaluate the 
differences between conservative management and LASER intervention for 
pregnancies diagnosed with stage I severe TTTS.   
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Specific Aims 
 The main objective of the present study is to look at the decision-making 
process of physicians and parents when Twin-to-Twin Transfusion Syndrome is 
diagnosed in monochorionic – diamniotic twins.   
 Specifically, 
i. Various scenarios of Twin-to-Twin Transfusion will be observed from the 
Fetal Treatment Program of New England and data about the syndrome’s 
progression, treatment, and overall outcome will be recorded. 
ii.  High Risk Obstetricians and Fetal Surgeon evaluations and 
recommendations for Twin-to-Twin Transfusion Syndrome (TTTS) will be 
examined, with primary focus on ethics. 
iii. Parental reactions and assessments, with emphasis on morality, towards 
Twin-to-Twin Transfusion Syndrome (TTTS) will be evaluated. 
 This study should demonstrate the vast ethical and moral dilemmas 
pertaining to Twin-to-Twin Transfusions Syndrome (TTTS) from physician and 
parental perspectives.   
 We hope that this study will shed light on the current ethical and moral 
issues in fetal medicine today.   
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Methods 
 During my six-month observational period from July 2012 through January 
2013, a cohort of women pregnant with monochorionic-diamniotic (identical) 
twins were evaluated at the Fetal Treatment Program of New England under 
Brown University Alpert Medical School for potential diagnosis of severe Twin-to-
Twin Transfusion Syndrome (TTTS).  Prior to referral, they had been routinely 
assessed in scheduled prenatal and ultrasound sonography appointments, based 
on the American College of Obstetricians and Gynecologists (ACOG) 
recommendations.  These recommendations include a first trimester (prior to 13 
weeks and 6 days gestation) ultrasound to determine cardiac activity, fetal 
number, amnionicity, and chorionicity (“ACOG Practice Bulletin No. 101,” 2009).  
Based on the finding of at least a multiple gestation pregnancy, the woman would 
be evaluated in subsequent second and third trimester ultrasounds for 
chorionicity, amnionicity, comparison of fetal sizes, estimation of amniotic fluid 
volume (increased, decreased, or normal) on each side of the membrane, and 
fetal genitalia (when visualized) (“ACOG Practice Bulletin No. 101,” 2009).  
Specifically, this includes a targeted and detailed ultrasound at 16-20 weeks 
gestation (second trimester) for evaluation of the developing twin fetuses’ growth, 
anatomy, and cardiac activity and if necessary other examinations including fetal 
Doppler ultrasonography, biophysical profile, amniotic fluid assessment, fetal 
echocardiography, or additional biometric measurements (“ACOG Practice 
Bulletin No. 101,” 2009). Each multi-gestation pregnancy management is on a 
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case-by-case basis, with emphasis centered around maternal health, obstetrical 
history, and laboratory abnormalities (“ACOG Practice Bulletin No. 101,” 2009).  
At the various prenatal and ultrasound appointments, morbidities of a multi-
gestation pregnancy are discussed at length and questions solicited and 
answered.  Morbidities discussed include, but are not limited, to preeclampsia, 
gestational diabetes, preterm labor, preterm delivery, and twin-to-twin transfusion 
syndrome.  
 Once referred to the Fetal Treatment Program for a consultation, the 
woman is scheduled for an additional targeted ultrasound with complete anatomy 
scan, placental location, umbilical cord insertion assessments of both twins, and 
fetal Doppler and echocardiogram.  The fetal Doppler ultrasound and 
echocardiogram help visualize and evaluate the fetuses’ hearts including heart 
valves and other various cardiac anatomical structures, as well as special 
attention towards blood flow through the fetal hearts, placenta, and umbilical cord 
vessels.  Using the Quintero Staging System, there are five stages of severe 
TTTS (R A Quintero et al., 1999).  Stage I is identified by the presence of 
oligohydramnios or anhydramnios in one amniotic sac, referred to as the donor 
twin’s sac, and polyhydramnios in the other amniotic sac, referred to as the 
recipient twin’s sac; Stage II includes Stage I identifiers as well as a non-visual 
bladder in the donor twin throughout ultrasound assessment; Stage III diagnosis 
includes Stage I characteristics and Doppler echocardiogram finding of absent or 
reversed end-diastolic flow (AEDF or REDF) in donor twin’s umbilical arteries 
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and/or pulsatile blood flow in the recipient twin’s umbilical vein and/or mitral or 
tricuspid valve regurgitation in the recipient’s heart, though TR is always 
associated with pulsatile UVF; Stage IV is diagnosed with the presents of 
hydrops in either the donor or recipient twin, which includes pleural or pericardial 
effusions, ascites, or scalp edema; Stage V is indicated by intrauterine fetal 
demise (IUFD) of either or both twins (R A Quintero et al., 1999).  
 Patients diagnosed with severe TTTS Stage I undergo weekly ultrasounds 
for evaluation of progression, regression, or stability of the syndrome, referred to 
as conservative, expectant management.  Upon progression to stages III, IV, or 
persistent stage II, laser ablation intervention is recommended.  Persistent Stage 
II is defined as fetuses presenting by ultrasound with Stage II characteristics for a 
week or longer.  Under general anesthesia and constant ultrasound imaging, a 
placental-free window is determined and an “open laparoscopy” technique used 
to enter the abdominal cavity.  The uterus’ myometrium is then exposed, and the 
recipient’s amniotic sac entered using a 20-gauge needle.  A sheath inserted 
over a guide wire serves as the endoscopic cannula (Luks et al., 2009).  A 
semirigid telescope is inserted into the amniotic sac through a cannula with 
additional ports for the laser fiber and irrigation (Luks et al., 2009).  The placenta 
with both cord insertions and vessels branching from the cords are explored.  
The unpaired communicating placental vessels (anastomoses) across the 
intertwin membrane of the donor twin and recipient twin’s amniotic sac are 
ablated using a diode laser at powers ranging from 5 to 15 Watt (Luks et al., 
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2009).  At the end of the surgery, a gelatin plug is inserted into place across the 
uterine opening, sealing the membranes and myometrium (Luks et al., 2009).  
This procedure allows the fetal twins to recover in utero by halting the 
pathophysiology of the syndrome.  Following surgery, the pregnant patients are 
treated with tocolytic agents and monitored for contractions and for 2 days 
postoperatively, ultrasounds are performed daily for evaluation of the syndrome’s 
status.  The woman is usually discharged home by the end of day 2 (Luks et al., 
2009).  Once discharged, patients are recommended to have bi-weekly 
ultrasounds for the first 2 weeks after surgery and then weekly or every other 
week ultrasounds thereafter, to monitor the donor and recipient twin’s health 
(Luks et al., 2009).   This also allows high-risk obstetricians (MFM obstetricians) 
to evaluate the laser surgery effectiveness, the unpredictable course of severe 
TTTS in the twins post surgery, and if necessary to suggest future 
recommendations for the pregnancy, including amnioreduction or delivery (Luks 
et al., 2009).  
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 Results  
 Of all women referred to the Fetal Treatment Program of New England 
during the 6-month period, 11 different scenarios of severe Twin-to-Twin 
Transfusion Syndrome patients were observed, evaluated, and treated by the 
Fetal Treatment Program.  Each scenario followed the course of treatment action 
stated above, but all differed in initial diagnosis, overall progression of the 
syndrome, and final outcomes of the pregnancy.  Furthermore, there were 
different levels of comprehension of severe TTTS as a syndrome, expression of 
diverse emotions experienced throughout the syndrome’s course, and the overall 
decision-making process varied with each scenario.   
Scenario A 
 A mid-thirty year old woman, presented with her first pregnancy of 
monochorionic–diamniotic twin boys after three rounds of in vitro fertilization 
(IVF).   She was well educated and presently employed at a law firm.  She was 
married with a supportive husband.  She initially presented at 21 weeks and 1 
day gestational age for a level II ultrasound.  Here, the twins were diagnosed with 
TTTS Stage I because of the presence of polyhydramnios in the recipient twin 
and oligohydramnios in the donor twin.  They were offered to enroll in a 
randomized study that compares observation with early surgical intervention in 
Stage I TTTS, but she and her husband decided for weekly ultrasound 
observation for progression of TTTS.  As of 22 weeks and 2 days, ultrasound 
indicated the TTTS was regressing and the twins no longer met criteria for TTTS 
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Stage I.  By 26 weeks and 2 days, there was significant improvement and 
potential resolution of TTTS.  Weekly ultrasounds continued without change from 
Stage 0 TTTS.  A 37-week ultrasound found single intrauterine fetal demise 
(IUFD) and her high-risk obstetrician then decided to deliver the live twin.   
 Throughout her pregnancy and the 16-week ordeal with her babies having 
TTTS, she expressed nervousness because of the potential for loss of the 
babies, which may have been her only pregnancy.  Before the initial diagnosis, 
she was well informed about TTTS and the likelihood of her twins having the 
disease.  Upon the initial diagnosis of Stage I, she and her husband felt it 
necessary to do whatever it took to have healthy and live babies since they had 
struggled to conceive naturally and have a history of infertility.  They also were 
realistic with the potential mortality and morbidity of the disease and the 
uncertainty of progression and regression.   Because of the significant 
improvement seen by 26 weeks, they both felt they had overcome the TTTS 
ordeal, but were surprised and heartbroken with the IUFD at 37 weeks.  As of 
today both are sadden by the loss, but are happy to have one live baby. 
Scenario B 
 An early-thirties, married woman with a supportive husband presented with 
a pregnancy of monochorionic–diamniotic twin boys.  This was her fifth 
pregnancy (she had four healthy children at home).  She presently was 
employed, but was taking a leave of absence due to the pregnancy.  Early in her 
pregnancy she experienced leaking fluid, which was deemed not to be PPROM 
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or early onset of labor.  At 18 weeks and 2 days, she was diagnosed with Stage 
III TTTS because the donor twin presented with oligohydramnios, no bladder 
seen, and pulsatile flow through the umbilical vein.  She underwent LASER 
surgery a day later, where five communicating placental vessels were ablated.  
Four days post-op, she experienced PPROM and as a result both donor and 
recipient twins had oligohydramnios throughout the rest of the pregnancy.  At 22 
weeks and 2 days, it was noted that the donor twin had reversed end-diastolic 
flow and a week later there was a donor twin demise.  By 24 weeks and 3 days, 
the recipient was delivered and passed away due to immature lung development 
and pulmonary hypertension.   
 She initially experienced overwhelming anxiety about the addition of two 
more children into the family that was unplanned, but overall both parents were 
excited.  She and her husband were nervous prior to surgery, but very thankful 
after it.  With the occurrence of PPROM, a side effect of surgery, they did not 
blame surgeons, but were understanding in that she had been experiencing fluid 
leaking throughout the pregnancy prior to surgery.  With the demise of the donor, 
the couple was devastated and expressed apprehension and worry for the 
recipient’s health.  Upon the birth of the recipient twin, the couple was able to 
hold him until he passed away.  Throughout the pregnancy and after the death of 
both twins, they remained very thankful for the medical support and knew the 




 A single, mid-twenties woman, with history of miscarriages, was pregnant 
with monochorionic–diamniotic twin boys.  She was unemployed, with a young 
son at home from the same partner; they both had emigrated from Liberia.  At 20 
weeks and 1 day gestational age (GA), she was diagnosed with Stage I TTTS 
because of oligohydramnios in the donor twin and polyhydramnios in the 
recipient twin.  By 21 weeks, there was demise of the donor twin, with ultrasound 
findings of hydrops and absent fetal heartbeat.  Since she no longer had TTTS 
with the demise of donor twin, it was recommended that she have weekly 
ultrasounds to evaluate the recipient twin’s health.   She missed her appointment 
the following week and at 22 weeks and 3 days presented to the emergency 
room (ER) with PPROM and preterm labor. Both twins were delivered.  The 
recipient was at a previable GA and passed away as a result.   
 With the unplanned pregnancy and the lack of knowledge with what TTTS is 
and its effects on her twins, the woman was unprepared for what occurred during 
her pregnancy.  She originally mentioned not wanting more children at the time, 
but came to terms with it.  At the ultrasound where a fetal demise was observed, 
she and her partner were unemotional to the news. Both of their commitment to 
the pregnancy was questioned when she missed her subsequent ultrasound and 
showed a lack of responsibility to get the care needed.  There was thought that 
there might have been other reasons the woman was not compliant with her 
prenatal care.  For example, she may have experienced fear, confusion, 
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depression, or lack of a mode of transportation. 
Scenario D 
 A late-twenties, married woman was pregnant with monochorionic-
diamniotic twin girls.  She had a very supportive husband and both were well 
educated and currently employed.  They had a son at home and very supportive 
extended family.  At 20 weeks and 5 days, the twins were diagnosed with Stage 
III TTTS.  The donor and the recipient twins presented with oligohydramnios and 
AEDF, and polyhydramnios and bi-ventricular hypertrophy, respectively.  The 
same day, LASER surgery was performed and five a total of communicating 
vessels were ablated.  By 21 weeks and 3 days, five days post-surgery, there 
was regression of Stage III TTTS and twins no longer met criteria for TTTS 
diagnosis.   Three days later donor twin showed decreased heart contractility, 
bradycardia, AEDF, and pulsatile umbilical venous flow.  At 24 weeks and 5 
days, the donor continued to show AEDF, but the recipient was also showing 
signs of pulmonary stenosis.  This continued through 27 weeks and 3 days, when 
the donor worsened with REDF, cephalization of blood flow, and hydrops.  At 28 
weeks and 3 days, there was donor demise by ultrasound and the recipient twin 
continued to show signs of pulmonary stenosis and slight right ventricular 
hypertrophy.  The recipient continued showing pulmonary stenosis and 
ventricular hypertrophy until her delivery at 35 weeks.  A balloon catheter was 
placed for her pulmonary stenosis and she is presently doing very well.   
 At the initial news of pregnancy and twin girls, the couple was very excited 
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for the new additions to the family.  With her pregnancy deemed a 
monochorionic-diamniotic one, they were very aware of the possibility, 
progression, and outcomes of TTTS once the twins were diagnosed.  When 
surgery was recommended, the woman expressed a lot of uneasiness and 
apprehension because of the thought of her and/or her twins dying.   Post 
surgery and until the demise of the donor, they experienced a “rollercoaster of 
feelings” because of the long time after surgery and the regularity of symptoms 
that the twins were experienced, but were still alive.  Upon the birth of the 
recipient twin, the couple was extremely glad and relieved to have their new 
addition. 
Scenario E 
 A married, mid-twenties woman was pregnant with monochorionic–
diamniotic twin girls.  This was the first pregnancy for her and her husband.  Both 
were presently working.  At 19 weeks and 2 days, their twins were diagnosed 
with Stage I TTTS because the donor and recipient had oligohydramnios and 
polyhydramnios, respectively.  The couple were given the option to enroll in a 
study and be randomized to conservative, expectant management with weekly 
ultrasounds or surgical intervention. The husband, with the woman’s agreement, 
selected weekly ultrasounds outside the study.  Throughout the time of initial 
diagnosis, the donor and recipient continued to have oligohydramnios and 
polyhydramnios, respectively, but the donor was also deemed IUGR and her 
high-risk OB recommended delivery if growth decreased or stopped.  At 34 
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weeks and 2 days gestation, two live twin girls were delivered.   
 The couple expressed excitement for the pregnancy. The wife’s mother was 
present at the diagnosis of TTTS and supportive of her daughter, daughter’s 
husband, and future grandchildren.  At the time of diagnosis, the couple was 
unaware of TTTS, but after the medical expert provided information about Stage I 
TTTS with all its uncertainty, they were thankful and wanted to take the 
syndrome one day a time.  The husband is supportive, but dominating when it 
came to decision-making.   With the birth of their twin girls, alive and well, the 
couple is ecstatic for their new family and relieved to have the risky pregnancy 
over.   
Scenario F 
 Early-thirties, married woman presented pregnant with monochorionic –
diamniotic twin boys.  She and her husband had two sons at home and a very 
supportive maternal grandmother.  Both parents were educated, currently 
working, and supportive of each other.  At 17 weeks, the twins were diagnosed 
with persistent Stage II TTTS after initial diagnosis of Stage II one day prior.  The 
recipient was found to have polyhydramnios and the donor was found to have 
oligohydramnios, no visible bladder, AEDF, and echogenic bowel.  They were 
offered genetic testing because of the echogenic bowel, but both declined.  The 
next day, LASER was performed with a total of seven communicating placental 
anastomoses ablated.  Four days post surgery and under ultrasound imaging, 
the twins no longer met criteria for TTTS, but the donor showed an echogenic 
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focus intracardiac.   At 22 weeks and 1 day, recipient demise was noted 
unexpectedly.  In the following five weeks, the donor was observed to have 
polyhydramnios and elevated middle cerebral artery (MCA) flow.  The woman’s 
water broke at 27 weeks and 1 day GA and was admitted to the hospital for 
steroid completion to help develop the donor twin’s lungs.  At 27 weeks and 4 
days, the donor twin was born via C-Section. 
 The couple had been very excited about the pregnancy and adding the two 
new twins to the family and future big brothers.  They did not want genetic testing 
performed prior to surgery because to them the outcome did not matter.  When 
surgery was recommended, both were not nervous, but prepared for the 
outcomes and practical.  They knew they were doing everything they could to 
save the babies.  Upon the recipient demise at 22 days after surgery, the couple 
was extremely upset, since they thought it was the donor twin that was the sicker 
of the two.  They were worried throughout the rest of the pregnancy until she 
went into the labor and the donor twin was born.  Both were able to hold the 
recipient for 2 hours after birth and felt closure upon doing so.  Currently, both 
mother and father are overjoyed with having one live twin baby and have come to 
terms with the death of the recipient twin. 
Scenario G 
 A mid-twenties, unmarried woman was pregnant with monochorionic - 
diamniotic twin girls.  This was her first pregnancy with her partner and both had 
no other children.  She was educated with a good job as a nurse and her partner 
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was currently attending school.  At 21 weeks and 2 days, the babies were 
diagnosed with Stage III TTTS based on the donor twin having no free fluid 
(anhydramnios), no visible bladder or stomach and the recipient twin having 
polyhydramnios and mild tricuspid regurgitation (TR).  The next day the woman 
underwent LASER surgery with a total of nine communicating placental vessels 
ablated. By 22 weeks and 1 day GA, the Stage III TTTS had regressed to Stage 
II TTTS with donor still having anhydramnios and no visible bladder and recipient 
having polyhydramnios, cephalization of blood flow, and elevated MCA flow.  At 
22 weeks and 5 days, there was donor twin demise, but the recipient continued 
to show polyhydramnios, cephalization of blood flow, and elevated MCA flow.  At 
23 weeks and 5 days, she was admitted for premature labor because of the 
shortening and funneling of her cervix.  At 26 weeks GA, the recipient twin was 
delivered because of rupture of demised donor side amniotic sac.   
   Initially the unplanned pregnancy came as a shock to the dating couple, 
who are currently thinking about marriage.   Upon the TTTS diagnosis, they were 
both realistic with the outcomes, morbidity, and mortality of the syndrome.  With 
surgery the maternal grandmother seemed overly excited that the syndrome was 
fixed and was unaware of the severity and unpredictability of TTTS even after 
surgery.  The couple was realistic about the uncertain future in the pregnancy, 
but was devastated with the demise of the donor twin 9 days after surgery and 
proceded with the rest of the pregnancy on a day by day basis.  Both were 
extremely surprised to have given birth to the recipient baby prematurely, but are 
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still happy and thankful.   
Scenario H 
 Early thirties, married woman was pregnant with monochorionic – 
diamniotic twin girls.  She and her husband had a son at home, who was born at 
30 weeks GA, with severe IUGR, and diagnosed with hypospadias postnatally.  
She also had a history of preeclampsia with her first pregnancy.   At 17 weeks 
GA, she was diagnosed with Stage II TTTS because the donor twin had no 
visible bladder and AEDF.  Five days later for re-evaluation of TTTS, the 
ultrasound found the donor twin to also have oligohydramnios.  Laser surgery 
was performed the same day with six placental anastomoses ablated.  Until 2 
weeks post-op, the recipient twin had polyhydramnios and the donor twin had 
AEDF.  The donor continued to have AEDF and IUGR, while the recipient twin’s 
polyhydramnios had resolved through 26 weeks and 4 days gestation.  At this 
time the high-risk obstetrician recommended the start of steroid treatment for 
fetal lung maturation. One week later, at 27 weeks and 4 days, both twin babies 
were delivered after a scheduled NST was performed and the donor twin showed 
no growth and tachycardia.   
 At the initial consultation for TTTS, the couple showed an unawareness of 
the severity of TTTS and a lack of comprehension on what it meant for their 
pregnancy and twin girls.  Five days later at their follow-up, they were more 
aware of the syndrome and its lack of predictability and expressed anxiousness 
with more questions asked to experts. Post-surgery, the couple still seemed to be 
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naive about the unpredictability of TTTS and the necessity for weekly 
ultrasounds, even with the potential improvement of the syndrome.  Overall, by 
the end of the pregnancy, the couple was extremely thankful and appreciative of 
the medical help and information they received at the Fetal Treatment Program 
of New England. 
Scenario I 
 An early-twenties, unmarried woman was pregnant with monochorionic –
diamniotic twin girls.  This was her first pregnancy with her boyfriend and was 
unplanned.  At 18 weeks and 3 days GA, the pregnancy was diagnosed with 
Stage I TTTS because the donor twin presented with oligohydramnios during 
ultrasound.  By 19 weeks and 1 day, the TTTS had progressed to Stage III 
because donor twin continued to have oligohydramnios and now presented no 
visible bladder and the recipient twin had tricuspid regurgitation, pulsatile 
umbilical venous flow, right ventricle hypokinesis, and some pulmonary stenosis.  
LASER surgery was performed the following day; here five placental 
communicating vessels were ablated.  Six days post-op, the twins showed signs 
of improvement with normal amniotic fluid levels.  At 23 weeks and 4 days, both 
donor and recipient had equal pockets of fluid, both had visible stomachs and 
bladders, and the recipient twin’s TR and right ventricular hypokinesia continued 
to improve.  As of 25 weeks and 3 days, both babies were deemed IUGR and 
were referred for bi-weekly evaluations for growth and NST, but the IUGR may 
have been constitutional due to that woman’s small stature.  The twin babies 
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continued to show indications of IUGR, but maintaining linear growth and fetal 
wellness until the woman’s water broke prematurely at 30 weeks and 5 days.  
One day later, both twins were delivered, treated in the NICU for prematurity, and 
are currently doing exceptionally well.   
 Mother of twins has a very supportive extended family, including parents, 
grandparents, and aunts.  Both the woman and her boyfriend were realistic with 
the diagnosis of TTTS and understood that it is unpredictable with each weekly 
ultrasound.  Throughout the pregnancy, she expressed an underlying anxiety 
disorder and was very stressed with not only the severe TTTS, but also with her 
boyfriend and father of the twins thinking about enlisting into the Marines to 
support their future family.  She stated not wanting to move away from her very 
supportive family, but understands him wanting to provide for their family.  At 
birth, the couple and family were excited about the new additions and were 
looking forward to a future together, whether near her family or not.   
Scenario J 
 Late-thirties, married woman pregnant with monochorionic –diamniotic twin 
boys.  She and her husband had a 3 year old at home, born at 37 weeks GA and 
diagnosed with hemiplegia.  Both husband and wife were very educated.  With 
the birth of their son, the woman decided to become a stay-at-home mom with 
her handicapped son and the husband continued to be the provider for the 
family.  At 22 weeks and 3 days GA, twins were diagnosed with Stage III TTTS; 
due to the donor twin having no visible bladder and oligohydramnios and the 
 31 
recipient twin presenting with polyhydramnios, pulsatile umbilical venous flow 
and TR.  The following day, the woman underwent LASER where eight 
communicating placental vessels were ablated.  At 23 weeks and 1 day, the 
donor showed anhydramnios, AEDF, and no visible bladder or stomach and the 
recipient showed polyhdramnios and slight pulsatile umbilical venous flow.  One 
week later, both twins continued to show the same symptoms, but both twins had 
stopped growing.  By 25 weeks and 5 days, the donor’s status had not changed 
and the recipient’s status had continued to worsen with cardiomegaly and global 
cardiac hypokinesia (which are both indicative of heart failure).  She underwent 
amnioreduction the same day to relieve pressure and the potential for PPROM.  
At 26 weeks and 1 day, she delivered two live babies via C-Section.  Two days 
later, at day two of life, both twins passed away. 
 The couple had no knowledge of severe TTTS prior to first consult at the 
Fetal Treatment Program of New England and the ultrasound evaluation and 
ultimate diagnosis was performed.  At the consult, she wanted only physicians 
present during ultrasound and diagnosis.  On day of surgery, maternal 
grandparents were present and supportive of the couple, especially towards their 
daughter and handicapped grandson.  Prior to going into surgery, woman 
refused to proceed unless physicians met with her.  She expressed to them the 
extreme fear of having another handicapped child and how she did not have the 
physical or emotion strength to care them.  The husband was supportive and 
caring of wife and family, but never wanted children and was neither 
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communicative nor emotional about his wants or needs in the pregnancy.  At the 
birth of the twins, both parents were confused on what type of care to give the 
babies and very depressed about the grim prognosis of the twins.  The couple 
was able to baptize babies prior to both twins passing and furthermore was able 
to finalize potential funeral arrangements.  Upon the demise of both twins, both 
mother and father were able to hold both babies together and gain closure with 
their passing away.  The next day, the woman was very emotional, but 
appropriately so and kept re-evaluating if she could have done anything more for 
the babies and especially expressed she didn’t want them to suffer.  The couple 
was overall very thankful for the medical help and support given to them and their 
twins. 
 Scenario K 
 An unmarried early thirties, woman presented with monochorionic-
diamniotic twin boys as her first pregnancy.  The mother had a high school level 
education and was currently unemployed.  The couple had been high-school 
sweethearts and recently got back together prior to finding out she was pregnant.  
At her ultrasound at 19 weeks and 1 day gestation, she was diagnosed with 
Stage III TTTS.  This was due to the donor twin with no visible bladder, 
intermittent AEDF, and oligohydramnios and the recipient twin with a MVP 
amniotic pocket of 13 cm consistent with polyhdramnios.  One day later, the 
woman underwent laser abalation of the communicating placental vessels 
between the twins, with a total of 6 vessels ablated.  At one day post surgery, the 
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twins showed no change since the ultrasound at 19 weeks and 1 day GA, except 
that the recipient twin’s MVP pocket had been lowered to 7.8cm.  At day 2 post-
op, based on ultrasound findings, there was complete reversal of TTTS with the 
donor twin showing a visual stomach and bladder, no longer AEDF, and a MVP 
of 1.37 cm.   Later in the day, the woman experienced PPROM, which is a 
complication of the surgery.  Two days later, at gestational age of 19 weeks and 
6 days, the woman and her boyfriend opted for augmentation of labor by 
induction and the previable twins were delivered.     
 Because of the fast progression of the TTTS from diagnosis to surgery, the 
couple was not initially knowledgeable of what TTTS and its mortality and 
morbidities were associated with it.  At diagnosis, all information about TTTS was 
divulged and the couple selected laser treatment.  On day of surgery, the future 
maternal grandmother was present along with the father of the twins, both very 
supportive of the woman.  The woman’s mother did not ask a lot of questions, but 
the boyfriend did while he tried to make a stressful situation more tolerable to the 
woman.  After the surgery, the couple expressed relief and thankfulness.  During 
the days post-op, they struggled with what the correct decisions were when it 
came to the induction of her labor and felt that if they did induce they weren’t 
giving the babies a chance to live.  The couple, though struggling with decisions 
on the future of the current pregnancy, were optimistic that they could have a 
child together one day in the future.  With extended family arrival to the hospital 
and the couple deciding to augment labor since the woman had naturally started 
 34 
contractions, the couple was at ease with their decision to deliver the twins.  
Once born, the couple did not want to see the twins, but their extended families 
did.  Overall, the couple grieved appropriately for the very rapid progression they 
experienced with the syndrome and were able to support each other and their 
families throughout the difficult time.  
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Discussion 
 Medical professionals and future parents, most importantly the mother, 
encompass and assume roles of decision-maker in each TTTS scenario.  
Throughout the course of the TTTS situation, both parties evaluate and address 
the syndrome with current experience and knowledge, both medically and 
personally, and evaluate what is best for themselves and the situation.  With 
each scenario observed, various struggles involved in the decision-making 
process became apparent, neither more significant than the next, but all 
imperative for each player in the process.  These two perspectives with 
associated dilemmas are discussed below.      
Physician’s Perspective 
 With their diverse medical education and specialized training, physicians 
learn to establish a differential diagnosis and develop a treatment course of 
action with various diseases.  But with prenatal diagnosis and treatment, 
physicians assume a position of uncertainty, especially with complications 
involving multiple pregnancies.  As the occurrence of multiples is a rarity in itself 
and a complication with the pregnancy is also rare, many physicians are not 
experienced in evaluating the condition and the decisions that go into its 
treatment.  Often, when higher order gestations are discovered, a conversation 
about selective termination is initiated because of the known high morbidity rate 
with each increasing order of multiples.  This raises ethical questions on what 
truly is the right decision.  These questions can include, what if the parents aren’t 
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open to terminating a fetus or there is no concrete evidence that one multiple is 
sicker than another?  Physicians may struggle with how to pick the multiple to 
terminate ethically.  It is these types of questions that are at the foundation of a 
prenatal consultation, whether in a singleton or multiple pregnancy, and evolve 
with each complication diagnosed and treated. 
 When it comes to the monochorionic - diamniotic twin complication of 
severe TTTS, ethics is an essential component for responsible clinical 
management and has to be incorporated into each decision of TTTS (Chervenak 
& McCullough, 2013; Skupski, Chervenak, & McCullough, 2007).  At the initial 
diagnosis of TTTS, a physician may struggle with the type of information to 
provide the parents/patients.  What is critical for the physician to convey to future 
parents?  Should a physician discuss feticide and reduction of one fetus?  In 
TTTS, the discussion of selective termination may be offered as a treatment for 
the syndrome, but comes with the associated dilemmas, as stated above.  In 
scenario F, what was deemed the “sicker” twin prior to surgery ultimately was not 
the sickest twin caused by severe TTTS because the “healthier” twin suffered an 
IUFD after surgery.  If the woman had elected selective termination of what was 
thought to be the “sicker” twin, she and her husband would currently not have a 
new baby in their family.  Should clinicians discuss the uncertain course of 
TTTS?  What about the potential life with a handicapped child or children and is 
there help out there when needed?  If the parents don’t want to intervene in the 
pregnancy, should physicians discuss the consequences?  Based on the 
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scenarios (A through K) observed, all of this information was critical for parents to 
know and discuss, whether parents/patients wanted to acknowledge its 
importance.  Making sure parents have all the information they possibly would 
need for their position in the decision-making process allows them to have an 
unbiased stance.  Physicians also may struggle with the timing factor for the 
disease.  What sufficient reflection time to give the parents when the initial 
diagnosis is made?  How urgent is intervention at the time of diagnosis?  And 
should there be multiple sessions of discussion about the facts of TTTS?  Based 
on the scenarios observed, the best answers to the questions of timing are 
unclear.  Each scenario is different when pertaining to time.  While most of the 
scenarios (B, F, G, H, J, K, and I) had a day between diagnosis and surgery to 
examine and come to terms with the information physicians provided about 
severe TTTS, some of these scenarios could have used more time between 
diagnosis and the scheduled intervention.  Scenarios J, K, and H expressed a 
lack of comprehension at the initial TTTS diagnosis and LASER surgery, but at 
the end of their TTTS ordeal felt overall well informed.  In contrast, scenario D, 
surgery was performed the same day as diagnosis, but mother and father had 
comprehended all the information and were comfortable in there decision to 
undergo LASER surgery.   
 Once the decision of LASER intervention is made, medical professionals 
must estimate the timing at which LASER is performed and thus define the actual 
health of the fetuses.  Standard protocol, at our institution, is providing LASER 
 38 
intervention prior to 26 weeks gestation because post 26 weeks the fetuses are 
viable outside the womb.  Of note, there are certain clinical staging parameters 
that are not necessarily indicative of TTTS at a certain gestational age.  The 
finding of absent end diastolic flow (AEDF) in one of the twins before 16 weeks 
gestation may be a normal finding, but found after 16-18 weeks is abnormal.  It 
represents Stage III TTTS and LASER intervention is recommended.  What is the 
difference between a 18-week fetus showing AEDF and is considered Stage I 
and referred for expectant management and the following week showing the 
same AEDF and is now considered Stage III and referred to LASER?  How does 
a physician standardize when AEDF is normal or not?  From the scenarios 
above, scenario D experienced this dilemma and eventually LASER was 
performed. Ultimately, only one baby survived because there was an IUFD of the 
co-twin.  But a question arises that would there have been survival of two babies 
if the surgery was performed a week earlier?  There is no answer to this 
question; one never knows how truly sick the babies are or how fast the severe 
TTTS is progressing.  Also, with the uncertain progression course of TTTS, 
questions arise with why LASER treatment isn’t available for all stages, not just 
persistent stage II, III, and IV.  Scenarios A, C, and E best demonstrate this 
predicament.  When all were diagnosed with Stage I TTTS each progression of 
the syndrome differed.  Scenario A experienced constant Stage I characteristics 
then regressed to showing no evidence of severe TTTS throughout the rest of 
the pregnancy until 37 weeks GA when there was an IUFD of one twin.  Scenario 
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C was originally diagnosed with Stage I and one day later there was a IUFD 
found of one twin and ten days later the other twin was lost because of pre-
viability once delivered.  As for scenario E, the twins were steady at stage I 
throughout the entire pregnancy and ultimately two live babies were delivered.  
Would LASER surgery have helped scenario A or C?  It is hard to tell, scenario C 
progressed to stage V within 24 hours of the initial diagnosis, so LASER probably 
would not have helped.  As for scenario A, there has to be more examination of 
stage I characteristics and LASER intervention to subdivide the high-risk stage I 
cases from the not high risk.  Overall, the real dilemma is if the physicians can’t 
select in advance which Stage I cases will progress, do they intervene on all 
Stage I cases to save scenarios like C or do they avoid unnecessary surgery on 
the mother in hope that the case will be like scenario E?  Lastly, the physician 
may struggle with post 26 week GA diagnosis of TTTS.  Why not perform 
LASER, even though the babies are viable outside the womb, since the main 
determinate of TTTS infant morbidities is prematurity.  Why not try to keep the 
infants in the mother’s womb as long as possible for proper development of the 
respiratory system?  The physician must weigh the morbidities that come with 
prematurity versus fetal mortality of TTTS if not delivered at the appropriate time.  
Which of these circumstances are considered appropriate for LASER treatment 
post 26-week gestation?  The Leiden Fetal Group of the Netherlands in 2007 
evaluated LASER surgery versus serial amnioreduction in diagnosed severe 
TTTS cases post 26 weeks GA and found less major neurological morbidity in 
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neonates because of the more advanced gestational age at birth in the laser 
group than the amnioreducation group (Middeldorp et al., 2007).  Though no 
scenarios above were diagnosed after 26 weeks GA, many of the infant deaths 
after delivery in the scenarios was due to prematurity and the underdevelopment 
of the infants’ lungs.   
 Physicians struggle with other dilemmas in TTTS.  Are weekly ultrasounds 
sufficient in evaluating severe TTTS at stage I or for follow-up of patients after 
LASER?  As stated above in scenarios A and E, weekly ultrasound indications of 
Stage I were sufficient, but there was an IUFD at 37 weeks GA in scenario A.  In 
contrast, for scenarios B, D, I, F, G, H, J, the weekly follow-up ultrasounds 
whether before or after LASER intervention, were beneficial because it allowed 
physicians to evaluate both the fetuses’ health and to intervene, if necessary.  As 
for amnioreduction as a treatment, it does not to offer a definitive repair for TTTS’ 
pathophysiology, but does provide relief to the mother carrying the twins and 
their extra amniotic fluid.  Physicians may struggle with the helpfulness of 
amnioreduction after LASER surgery has been performed.  It can cause PPROM 
or preterm labor, as in scenario B, J, and K, and thus result in the delivery of pre-
viable or premature infants who later pass away.  As for LASER surgery, the fetal 
surgeon may come across different situations of decision-making, such as do the 
risks towards the mother by performing surgery outweigh the benefits to the sick 
twins?  In all of the scenarios of severe TTTS, the mothers carrying the twins 
were not the sick patients, but were undergoing surgery and putting themselves 
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at risk for various morbidities associated with surgery.  In purely technical terms, 
AV anastomoses are thought to be the major problems in severe TTTS’ 
pathophysiology.  AA anastomoses are thought to have a protective role against 
the syndrome.  Should a fetal surgeon ablate only the AV anastomoses and 
leave the AA anastomoses?  If one twin were to die and AA anastomoses were 
left patent, this would allow exsanguination of the live twin and could result in 
neurological damage.  What about missing anastomoses in general?  In some 
TTTS cases with an anterior placenta, it is much tougher to visualize all the 
placental anastomoses than with posterior placentas because of the angle of the 
scope and the laser fiber.  No scenarios showed signs of exsanguination caused 
neurological outcomes, but it is too early to evaluate the neonates.  Lastly, does 
sequential LASER ablation of AV anastomoses from donor-to-recipient first, then 
the ablation of AV from recipient-to-donor actually improve survival of the twins?  
All scenarios above that underwent LASER surgery were not performed 
sequentially and resulted in dual twin survivals in two scenarios, one twin 
surviving in 3 scenarios, and dual twin demise in 3 scenarios.  Overall the 
percentage of at least on twin surviving after LASER interventions for all the 
scenarios observed was 62%, lower than is expected (80%), but this could be 
due to the low number of scenarios.   
Patient’s Perspective 
 The parents of the twins, especially the mother, experience a moral struggle 
and take a position very different from a physician in decision-making.  Whereas 
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the physician comes from a background of both directive and non-directive 
counseling and evaluation, the parents take into account more individual needs, 
emotions, and personal ideals when making decisions about the care for their 
twins diagnosed with severe TTTS.   
  Prior to the pregnancy being diagnosed with severe TTTS, the conceiving 
of a baby can cause numerous different reactions for the couple based on their 
morals.  Many questions tend to run through the parents’ mind, and these 
differed in importance with each scenario observed.  First, basic questions not 
pertaining to severe TTTS could be asked.  Was the pregnancy planned?  What 
are the ages of the parents?  Are they teenagers?  Is the couple committed and 
monogamous in their relationship?  Is the couple supportive of each other? Is this 
the first pregnancy?  Could this be the couple’s last chance to have a child?  
Have they experienced infertility issues?  How many rounds of IVF has the 
couple undergone?  Are there children at home and can they financial support 
their new or expanding family?  Is there an added stress with twins or multiples, 
compared with a singleton pregnancy?  All these questions and their answers 
alter the mind frame of a couple and their individual stance of the pending 
pregnancy.  These questions, furthermore, set the framework of decision-making 
in the future of the pregnancy, whether complications are experienced or not.   
 With the diagnosis of severe TTTS, the couple reflects back on the 
questions above and new questions and opinions are expressed with decision 
dilemmas experienced in TTTS.  In some of the scenarios, the parents were 
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never told of the risk their twins could develop severe TTTS and as a result of the 
diagnosis, felt blind-sided and did not understand the severity.  Scenarios H and 
J best illustrate this predicament.  Their unawareness of severe TTTS didn’t 
allow them to understand the severity and timeframe from diagnosis to 
intervention.  In both scenarios, the severity of the diagnosis and its mortality and 
morbidity rates were not understood until after a few days of reflection, and even 
then both experienced high levels of anxiety.  Also, in all scenarios, parents were 
provided with numerous facts, options, and percentages from medical 
professionals.  These percentages of having one, two, or no babies, or what risks 
are for the babies, once born, to have a neurological, cardiac, or some other 
handicaps, short- or long-term, stick in the parent’s mind.  All scenarios reacted 
differently to all the information.  In most scenarios (A,B,D,F,G, K, and I), they 
knew of the syndrome and its risks, but wanted to do everything for their twins’ 
survival, whether or not they may be handicapped.  As for scenario J, the 
potential to have to care for other handicapped children in addition to their 
handicapped child at home was too much for the couple to handle.  They were 
not realistic in the facts of TTTS, but still wanted to provide their twins every 
possible chance to live, as long as there was no handicap.   
 Couples are also told what the options are, whether weekly observation, 
amnioreduction, or LASER surgery, depending on the stage.  As a result, the 
couple’s reaction and decision-making from diagnosis to treatment to outcome 
varied from scenario to scenario.  Two emotional paths emerge; a path from 
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hope to acceptance and a path from distancing to denial (Sommerseth & 
Sundby, 2010). Scenarios A, B, D, E, F, G, K, and I expressed emotions from 
hope at diagnosis to acceptance of the pregnancy outcome.  In this path, the 
couples, generally at diagnosis, were hopeful that the clinician’s 
recommendations would result in two health twins they would take home in the 
future.  All named the twins and planned their future with the new additions to the 
family.  The feeling of hope turned to acceptance in all of the scenarios at the 
conclusion of the pregnancy.  Whether two twins were born or not, each scenario 
experienced heartache, but understood that this is the unpredictability of TTTS 
and accepted it.  Scenarios C, H, and J experienced the path of distancing to 
denial.  In these three scenarios, the parents distanced themselves from 
developing feelings for the fetal twins once diagnosed.  They did not name the 
twins and did not want to accept the possible morbidity of TTTS.  They, too, 
experienced heartache with the death of the twins, if it occurred, and the 
unpredictability of TTTS, but knew they provided them with the best chance. 
 After intervention is performed, parents can struggle with surprises that 
come with follow-up ultrasounds because of TTTS’ unpredictability.  With each 
follow-up, there was still potential to lose one or both fetuses even with LASER 
intervention, or the possibility of the babies’ health not to turn around or just 
getting worse, as seen in scenarios D and J.  In scenario D, one twin after 
LASER intervention never recovered and held on to life for many weeks before 
passing away. This resulted in the parents experiencing a rollercoaster of 
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emotions and having to make decisions based on those emotions.  As for 
scenario J, both twins’ health never got better after LASER and it ultimately led to 
premature delivery and death of both babies.  The couple in scenario J struggled 
with making the right decision about the care of their premature infants.  There 
also may be the potential for the physician to opt for early delivery of the twins, 
whether the twins are IUGR or there is a complication of surgery, and the parents 
may struggle with the risk of morbidities due to prematurity (as the determining 
factor of short- and long-term problems in TTTS).  Scenarios B, D, E, F, G, H, I, 
and K all experienced delivery of at least one premature infant and toiled over the 
decisions for the neonatal care.  Scenario K, in particular, struggled with the 
decision to induce the delivery or keep the babies in the womb once PPROM had 
occurred, because they wanted to give the twins the best chance of survival.  
The babies were delivered pre-viable, but the couple came to terms that they 
would be able to have other children in the future. 
  Finally, emotions and morals play a role in coping.  With the final outcomes 
of the pregnancy and its progression to that state being different in all scenarios, 
the coping mechanisms of the couples varied.  Most couples struggled to cope 
with the loss of one or both twins, as in scenarios B, D, F, G, J, and K, and used 
different beliefs to cope with the loses.  Beliefs included the potential for future 
children, while others focused children at home, and some looked to extended 
family and their partner for help and support.  Coping methods also differed in 
each scenario because of the diverse level of education and occupation status in 
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each scenario and their ability to divert their attention away from the uncertainty 
of their TTTS’ path.    
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Conclusion 
 When it comes to decision-making in severe Twin-to-Twin Transfusion, 
there is no correct answer.  Whether from an ethical or moral standpoint, the 
dilemmas faced by medical physicians and parents are limitless in nature and 
difficult for each party to confront.  The explanation of John Rawls’ conception of 
“justice is fairness” in the veil of ignorance stance is described by an agreement 
that is fair to all parties in a situation by not acknowledging their own personal 
position (Freeman, 2012).  If both medical professionals and patients view the 
various severe TTTS dilemmas through a veil of ignorance and respect each 
party’s autonomy in the decision-making process, the struggles that encountered 
can be resolved in manner where both contributors and ultimately the twin babies 
benefit.  
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